Gilles Samyn logo

Gilles Samyn

Description

Gilles Samyn is an accomplished business leader and experienced board member. He is a director of EyeD Pharma since 2018.

Investor Profile

Gilles Samyn has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown rounds (top funding stages).
  • Majority of deals are located in Belgium.
  • Strong thematic focus on Biopharma, Biotechnology, Pharmaceutical.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • Belgium (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Gilles Samyn frequently co-invest with?

Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
QI
Europe, Oost-Vlaanderen, Belgium, Ghent
Co-Investments: 1

Which angels does Gilles Samyn often collaborate with?

DK
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1
FB
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1

What are some of recent deals done by Gilles Samyn?

EyeD Pharma

Liège, Liege, Belgium

EyeD Pharma is a pharmaceutical company dedicated to the development of innovative drug products in ophthalmology.

BiopharmaBiotechnologyPharmaceutical
Series UnknownMay 20, 2019
Amount Raised: $31,269,124